Greenleaf Trust Viatris Inc Transaction History

Greenleaf Trust

$10.7 Billion
Q1 2024

A detailed history of Greenleaf Trust transactions in Viatris Inc stock. As of the latest transaction made, Greenleaf Trust holds 29,974 shares of VTRS stock, worth $311,130. This represents 0.0% of its overall portfolio holdings.

Number of Shares

29,974

Previous 29,735 0.8%

Holding current value

$311,130

Previous $322,000 10.87%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 29, 2024	BUY	$11.27 - $13.53 $2,693 - $3,233	239 Added 0.8%	29,974 $357,000
Q4 2023 Jan 31, 2024	SELL	$8.77 - $10.85 $117,991 - $145,975	-13,454 Reduced 31.15%	29,735 $322,000
Q3 2023 Nov 09, 2023	BUY	$9.59 - $11.35 $6,818 - $8,069	711 Added 1.67%	43,189 $425,000
Q2 2023 Aug 09, 2023	SELL	$9.02 - $10.29 $2,092 - $2,387	-232 Reduced 0.54%	42,478 $423,000
Q1 2023 May 11, 2023	BUY	$9.2 - $12.26 $42,862 - $57,119	4,659 Added 12.24%	42,710 $410,000

Q4 2022 Jan 25, 2023	BUY	$8.72 - $11.56 $78,113 - $103,554	8,958 Added 30.79%	38,051 $424,000
Q3 2022 Nov 10, 2022	BUY	$8.48 - $11.13 $2,391 - $3,138	282 Added 0.98%	29,093 $248,000
Q2 2022 Aug 12, 2022	SELL	$9.95 - $12.27 $2,039 - $2,515	-205 Reduced 0.71%	28,811 $302,000
Q1 2022 Apr 27, 2022	BUY	$9.81 - $15.4 $7,386 - $11,596	753 Added 2.66%	29,016 $316,000
Q4 2021 Feb 11, 2022	SELL	$12.09 - $14.68 $18,328 - $22,254	-1,516 Reduced 5.09%	28,263 $382,000
Q3 2021 Nov 12, 2021	SELL	$13.25 - $15.13 $37,206 - $42,485	-2,808 Reduced 8.62%	29,779 $404,000
Q2 2021 Aug 10, 2021	SELL	$12.97 - $16.15 $58,455 - $72,788	-4,507 Reduced 12.15%	32,587 $466,000
Q1 2021 Apr 30, 2021	SELL	$13.59 - $18.54 $134,622 - $183,657	-9,906 Reduced 21.08%	37,094 $518,000
Q4 2020 Feb 08, 2021	BUY	$14.3 - $18.74 $672,100 - $880,779	47,000 New	47,000 $881,000

Others Institutions Holding VTRS

# of Institutions

1,099

Shares Held

945M

Call Options Held

3.49M

Put Options Held

2.6M

View Full List

About Viatris Inc

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $12.6B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

More about VTRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Greenleaf Trust, based on Form 13F filings with the SEC.

News

Stay updated on Greenleaf Trust with notifications on news.

Account